D-1029-2018 Class II Terminated
FDA drug recall D-1029-2018 was initiated by Bryant Ranch Prepack Inc. on Jul 27, 2018 and is designated Class II. Reason for recall: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. The recall status is terminated (terminated Apr 22, 2021). Affected quantity: 90 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 8, 2018
- Initiation Date
- Jul 27, 2018
- Termination Date
- Apr 22, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 90 tablets
Product description
Valsartan 320 mg tablets, 90-count bottles ( NDC 71335-0567-2), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504.
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Distribution pattern
Product was distributed in HI, IN, and FL.
Code information
Lot # 120879; Exp 10/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1029-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026